Literature DB >> 1694927

Essential hypertension: an insulin-resistant state.

E Ferrannini1, S M Haffner, M P Stern.   

Abstract

Epidemiological evidence supports a link between hyperinsulinemia and blood pressure. In nondiabetic, normotensive individuals, the male sex, age, obesity, and body fat distribution all are associated with higher systolic and diastolic blood pressure and with higher plasma insulin concentrations. Nevertheless, when accounting for the above physiological variables, blood pressure still is independently related to plasma insulin. In the general population, hypertensive individuals have multiple metabolic abnormalities (glucose intolerance, hyperinsulinemia, and dyslipidemia). A striking pattern of overlap exists among obesity, diabetes, and hypertension. Physiological studies (euglycemic insulin clamp) have shown that essential hypertension per se is a state of insulin resistance: lean, nondiabetic subjects with untreated hypertension have a mean 40% reduction in the ability of physiological hyperinsulinemia to stimulate whole-body glucose uptake. Other insulin actions (suppression of hepatic glucose output, lipolysis, lipid oxidation, and promotion of K+ uptake) are conspicuously preserved. In perfused forearm studies, local (intra-arterial) hyperinsulinemia induces subnormal rates of glucose uptake and glycogen synthesis in the skeletal muscle of individuals with essential hypertension. In the San Antonio Heart Study, parental history of non-insulin-dependent diabetes mellitus (NIDDM) is associated with hyperinsulinemia and higher blood pressure and serum lipid levels in nondiabetic probands. In this biethnic population, however, hyperinsulinemia and NIDDM are more prevalent (approximately threefold) among Mexican-Americans than non-Hispanic whites, but hypertension is more prevalent among the latter.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694927

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  20 in total

1.  The glycogen synthase gene in NIDDM and hypertension.

Authors:  Y Hamada; H Ikegami; Y Fujioka; E Yamato; K Takekawa; T Fujisawa; Y Nakagawa; H Ueda; J Fu; G Q Shen
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

Review 2.  Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Xuan Li; Zhen Wang; Alan J Mouton; John E Hall
Journal:  Can J Cardiol       Date:  2020-02-12       Impact factor: 5.223

3.  Low density lipoprotein enhances the cellular action of arginine vasopressin in rat glomerular mesangial cells in culture.

Authors:  S Ishikawa; M Kawasumi; K Okada; T Saito
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 4.  Which diuretic to use?

Authors:  C R Swanepoel
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

5.  Relation of birthweight to maternal plasma glucose and insulin concentrations during normal pregnancy.

Authors:  M C Breschi; G Seghieri; G Bartolomei; A Gironi; S Baldi; E Ferrannini
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

6.  Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.

Authors:  Paolo Tessari; Diego Cecchet; Alessandra Cosma; Monica Vettore; Anna Coracina; Renato Millioni; Elisabetta Iori; Lucia Puricelli; Angelo Avogaro; Monica Vedovato
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

7.  Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients.

Authors:  R Fogari; A Zoppi; L Corradi; P Lazzari; A Mugellini; P Lusardi
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

8.  Elevated systolic blood pressure in male GH transgenic mice is age dependent.

Authors:  Adam Jara; Chance M Benner; Don Sim; Xingbo Liu; Edward O List; Lara A Householder; Darlene E Berryman; John J Kopchick
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

9.  All roads bring to Rome: a different way for predicting success in the therapy of obesity through psychological features.

Authors:  Francesco Rotella; Lisa Lazzeretti; Valeria Barbaro; Giovanni Castellini; Michela Bigiarini; Barbara Cresci; Valdo Ricca; Carlo Maria Rotella; Edoardo Mannucci
Journal:  J Endocrinol Invest       Date:  2014-07-20       Impact factor: 4.256

10.  Correlation between changes of blood pressure with insulin resistance in type 2 diabetes mellitus with 4 weeks of pioglitazone therapy.

Authors:  L M Hettihewa; S S Jayasinghe; K G Imendra; T P Weerarathna
Journal:  Int J Diabetes Dev Ctries       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.